• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.COL4A4基因的基因组结构及导致常染色体隐性遗传性奥尔波特综合征的新突变的测定。
Am J Hum Genet. 1998 Nov;63(5):1329-40. doi: 10.1086/302106.
2
Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport syndrome.人类IV型胶原基因COL4A3的结构与常染色体隐性遗传性阿尔波特综合征中的突变
J Am Soc Nephrol. 2001 Jan;12(1):97-106. doi: 10.1681/ASN.V12197.
3
COL4A4 mutation in thin basement membrane disease previously described in Alport syndrome.薄基底膜肾病中的COL4A4突变,先前在Alport综合征中已有描述。
Kidney Int. 2001 Aug;60(2):480-3. doi: 10.1046/j.1523-1755.2001.060002480.x.
4
A single-base mutation in exon 31 converting glycine 852 to arginine in the collagenous domain in an Alport syndrome patient.
Nephron. 1996;74(2):333-6. doi: 10.1159/000189331.
5
Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.由于IV型胶原α4基因突变导致的良性家族性血尿。
J Clin Invest. 1996 Sep 1;98(5):1114-8. doi: 10.1172/JCI118893.
6
Three novel COL4A4 mutations resulting in stop codons and their clinical effects in autosomal recessive Alport syndrome.导致终止密码子的三种新型COL4A4突变及其在常染色体隐性遗传性阿尔波特综合征中的临床效应
Hum Mutat. 2002 Oct;20(4):321-2. doi: 10.1002/humu.9065.
7
Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.在遗传性膜疾病中鉴定出9种新的COL4A3和COL4A4突变及多态性。
Pediatr Nephrol. 2007 May;22(5):652-7. doi: 10.1007/s00467-006-0393-y. Epub 2007 Jan 10.
8
Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome.
Hum Mol Genet. 1994 Aug;3(8):1269-73. doi: 10.1093/hmg/3.8.1269.
9
Autosomal recessive Alport syndrome: mutation in the COL4A3 gene in a woman with Alport syndrome and posttransplant antiglomerular basement membrane nephritis.常染色体隐性遗传性奥尔波特综合征:一名患有奥尔波特综合征及移植后抗肾小球基底膜肾炎的女性的COL4A3基因突变。
J Am Soc Nephrol. 1995 Mar;5(9):1714-7. doi: 10.1681/ASN.V591714.
10
A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.COL4A3基因的一种新突变对Alport综合征和薄基底膜肾病有不同影响。
Am J Nephrol. 2007;27(5):538-44. doi: 10.1159/000107666. Epub 2007 Aug 24.

引用本文的文献

1
Phenotype-genotype correlations in patients with Alport syndrome from the Polish population.波兰人群中阿尔波特综合征患者的表型-基因型相关性
J Nephrol. 2025 Apr 16. doi: 10.1007/s40620-025-02251-3.
2
Pathological diagnosis of Alport syndrome.Alport综合征的病理诊断。
Kidney Res Clin Pract. 2025 May;44(3):406-410. doi: 10.23876/j.krcp.24.063. Epub 2024 Aug 23.
3
Alport Syndrome: Clinical Utility of Early Genetic Diagnosis in Children.Alport 综合征:儿童早期基因诊断的临床应用。
Genes (Basel). 2024 Aug 2;15(8):1016. doi: 10.3390/genes15081016.
4
An unusual case of nephrotic syndrome.一例不寻常的肾病综合征。
Pediatr Nephrol. 2024 Nov;39(11):3205-3208. doi: 10.1007/s00467-024-06408-3. Epub 2024 May 23.
5
Abnormal mRNA Splicing Effect of to Unclassified Variants.至未分类变异体的异常mRNA剪接效应。
Kidney Int Rep. 2023 Apr 10;8(7):1399-1406. doi: 10.1016/j.ekir.2023.04.001. eCollection 2023 Jul.
6
Identification of variants in Chinese patients with familial hematuria.中国家族性血尿患者变异的鉴定。
Front Genet. 2023 Jan 9;13:1064491. doi: 10.3389/fgene.2022.1064491. eCollection 2022.
7
Ocular Manifestations in Patients with Sensorineural Hearing Loss.感音神经性听力损失患者的眼部表现
J Ophthalmic Vis Res. 2022 Nov 29;17(4):551-573. doi: 10.18502/jovr.v17i4.12321. eCollection 2022 Oct-Dec.
8
Genetic testing and glomerular hematuria-A nephrologist's perspective.遗传性肾小球血尿的基因检测:肾内科医生的视角。
Am J Med Genet C Semin Med Genet. 2022 Sep;190(3):399-403. doi: 10.1002/ajmg.c.31987. Epub 2022 Jul 1.
9
Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome.在Alport综合征小鼠模型中,螺内酯在雷米普利治疗基础上的器官保护作用。
J Clin Med. 2021 Jun 30;10(13):2958. doi: 10.3390/jcm10132958.
10
Multidisciplinary Management of Alport Syndrome: Current Perspectives.奥尔波特综合征的多学科管理:当前观点
J Multidiscip Healthc. 2021 May 21;14:1169-1180. doi: 10.2147/JMDH.S284784. eCollection 2021.

本文引用的文献

1
Two genes, COL4A3 and COL4A4 coding for the human alpha3(IV) and alpha4(IV) collagen chains are arranged head-to-head on chromosome 2q36.编码人类α3(IV)和α4(IV)胶原链的两个基因COL4A3和COL4A4在2号染色体q36区域呈头对头排列。
FEBS Lett. 1998 Mar 6;424(1-2):11-6. doi: 10.1016/s0014-5793(98)00128-8.
2
A novel gene that encodes a protein with a putative src homology 3 domain is a candidate gene for familial juvenile nephronophthisis.一个编码具有假定src同源3结构域蛋白质的新基因是家族性青少年肾单位肾痨的候选基因。
Hum Mol Genet. 1997 Dec;6(13):2317-23. doi: 10.1093/hmg/6.13.2317.
3
Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4).常染色体显性遗传性阿尔波特综合征与IV型胶原α3和α4基因(COL4A3和COL4A4)相关。
Nephrol Dial Transplant. 1997 Aug;12(8):1595-9. doi: 10.1093/ndt/12.8.1595.
4
The clinical spectrum of type IV collagen mutations.IV型胶原突变的临床谱。
Hum Mutat. 1997;9(6):477-99. doi: 10.1002/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.0.CO;2-#.
5
The human gene mutation database.人类基因突变数据库。
Trends Genet. 1997 Mar;13(3):121-2. doi: 10.1016/s0168-9525(97)01068-8.
6
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome.X连锁遗传性肾炎中COL4A5胶原蛋白基因突变谱
Am J Hum Genet. 1996 Dec;59(6):1221-32.
7
Structure and physical mapping of DR1, a TATA-binding protein-associated phosphoprotein gene, to chromosome 1p22.1 and its exclusion in Stargardt disease (STGD).DR1(一种与TATA结合蛋白相关的磷蛋白基因)的结构与物理图谱绘制至染色体1p22.1及其在Stargardt病(STGD)中的排除。
Genomics. 1996 Sep 15;36(3):554-6. doi: 10.1006/geno.1996.0508.
8
Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.由于IV型胶原α4基因突变导致的良性家族性血尿。
J Clin Invest. 1996 Sep 1;98(5):1114-8. doi: 10.1172/JCI118893.
9
cDNA isolation and partial gene structure of the human alpha 4(IV) collagen chain.人α4(IV)胶原链的cDNA分离及部分基因结构
FEBS Lett. 1993 Sep 13;330(2):122-8. doi: 10.1016/0014-5793(93)80256-t.
10
A first-generation physical map of the human genome.人类基因组的第一代物理图谱。
Nature. 1993 Dec 16;366(6456):698-701. doi: 10.1038/366698a0.

COL4A4基因的基因组结构及导致常染色体隐性遗传性奥尔波特综合征的新突变的测定。

Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome.

作者信息

Boye E, Mollet G, Forestier L, Cohen-Solal L, Heidet L, Cochat P, Grünfeld J P, Palcoux J B, Gubler M C, Antignac C

机构信息

INSERM U423, Hôpital Necker-Enfants Malades, Paris, France.

出版信息

Am J Hum Genet. 1998 Nov;63(5):1329-40. doi: 10.1086/302106.

DOI:10.1086/302106
PMID:9792860
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1377543/
Abstract

Autosomal recessive Alport syndrome is a progressive hematuric glomerulonephritis characterized by glomerular basement membrane abnormalities and associated with mutations in either the COL4A3 or the COL4A4 gene, which encode the alpha3 and alpha4 type IV collagen chains, respectively. To date, mutation screening in the two genes has been hampered by the lack of genomic structure information. We report here the complete characterization of the 48 exons of the COL4A4 gene, a comprehensive gene screen, and the subsequent detection of 10 novel mutations in eight patients diagnosed with autosomal recessive Alport syndrome. Furthermore, we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers, in 11.5% of all control individuals, and in one control individual homozygous for this glycine substitution. There has been no previous finding of a glycine substitution that is not associated with any obvious phenotype in homozygous individuals.

摘要

常染色体隐性遗传性奥尔波特综合征是一种进行性血尿性肾小球肾炎,其特征为肾小球基底膜异常,与分别编码α3和α4IV型胶原链的COL4A3或COL4A4基因突变相关。迄今为止,由于缺乏基因组结构信息,对这两个基因的突变筛查受到阻碍。我们在此报告COL4A4基因48个外显子的完整特征、全面的基因筛查,以及随后在8例被诊断为常染色体隐性遗传性奥尔波特综合征的患者中检测到10个新突变。此外,我们在胶原结构域中鉴定出一个甘氨酸到丙氨酸的替换,在所有对照个体的11.5%以及一名该甘氨酸替换纯合的对照个体中,该替换在杂合携带者中显然无明显表型。此前尚未发现纯合个体中存在与任何明显表型无关的甘氨酸替换。